Vascular risk factors for atherosclerotic lesions of the middle cerebral artery detected by magnetic resonance angiography (MRA)

Acta Neurologica Scandinavica

Volumn 100, Issue 6, 1999, Pages 395-399

  Takahashi, K ^a   Kitani, M ^b   Fukuda, H ^b   Kobayashi, S ^b  

^a Masuda Red Cross Hospital   (Japan)

^b NONE

Author keywords

Atherosclerosis; Lipoprotein (a); Magnetic resonance angiography (MRA); Middle cerebral artery (MCA); Risk factor

Indexed keywords

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BRAIN BLOOD FLOW; FEMALE; HUMAN; HYPERTENSION; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; RISK FACTOR; STROKE;

EID: 0032706397     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1999.tb01059.x     Document Type: Article

References (32)

1. 1. HANDA N, MATSUMOTO M, MAEDA H et al. Ultrasonic evaluation of early carotid atherosclerosis. Stroke 1990;21: 1567-72.
2. 2. FINE-EDELSTEIN JS, WOLF PA, O'LEARY DH et al. Precursors of extracranial carotid atherosclerosis in the Framingham study. Neurology 1994;44:1046-50.
3. 3. DEMPSEY RJ, DIANA AL, MOORE RW. Thickness of carotid artery atherosclerotic plaque and ischemic risk. Neurosurgery 1990;27:343-8.
4. 4. CROUSE JR, TOOLE JF, MCKINNEY WM et al. Risk factors for extracranial carotid artery atherosclerosis. Stroke 1987; 18:990-6.
5. 5. GORELICK PB, CAPLAN LR, HIER DB, PARKER SL, PATEL D. Racial differences in the distribution of anterior circulation occlusive disease. Neurology 1984;34:54-9.
6. 6. TOMITA T, MIHARA H. Cerebral angiographic study on C.V.D. in Japan. Angiology 1972;23:228-39.
7. 7. INZITARI D, HACHINSKI VC, TAYLOR DW, BARNETT HJM. Racial differences in the anterior circulation in cerebrovascular disease. Arch Neurol 1990;47:1080-4.
8. 8. FELDMANN E, DANEAULT N, KWAN E et al. Chinese-white differences in the distribution of occlusive cerebrovascular disease. Neurology 1990;40:1541-5.
9. 9. KUSHNER MJ, ZANETTE EM, BASTIANELLO S et al. Transcranial Doppler in acute hemispheric brain infarction. Neurology 1991;41:109-13.
10. 10. KAPS M, TESCHENDORF U, DORNDORF W. Haemodynamic studies in early stroke. J Neurol 1992;239:138-42.
11. 11. KOROGI Y, TAKAHASHI M, MABUCHI N et al. Intracranial vascular stenosis and occlusion: Diagnostic accuracy of three-dimensional, fourier transform, time-of-flight MR angiography. Radiology 1994;193:187-93.
12. 12. UEHARA T, MORI E, TABUCHI M, OHSUMI Y, YAMADORI A. Detection of occlusive lesions in intracranial arteries by three-dimensional time-of-flight magnetic resonance angiography. Cerebrovasc Dis 1994;4:365-70.
13. 13. WONG KS, LAM WWM, LIANG E, HUANG YN, CHAN YL, KAY R. Variability of magnetic resonance angiography and computed tomography angiography in grading middle cerebral artery stenosis. Stroke 1996;27:1084-7.
14. 14. WONG KS, LIANG EY, LAM WWM, HUANG YM, KAY R. Spiral computed tomography angiography in the assessment of middle cerebral artery occlusive disease. J Neurol Neurosurg Psychiatry 1995;59:537-9.
15. 15. MURAI A, MIYAHARA T, FUJIMOTO N, MATSUDA M, KAMEYAMA M. Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. Atherosclerosis 1986;59:199-204.
16. 16. JURGENS G, KÖLTRINGER P. Lipoprotein(a) in ischemic cerebrovascular disease: A new approach to the assessment of risk for stroke. Neurology 1987;37:513-15.
17. 17. WOO J, LAU E, LAM CWK et al. Hypertension, lipoprotein(a), and apoliopoprotein A-I as risk factors for stroke in the Chinese. Stroke 1991;22:203-8.
18. 18. ZENKER G, KÖLTRINGER P, BONE G, NIEDERKORN K, PFEIFFER K, JURGENS G. Lipoprotein(a) as a strong indicator for cerebrovascular disease. Stroke 1986;17:942-5.
19. 19. UEHARA T, TABUCHI M, MORI E. Frequency and clinical correlates of occlusive lesions of cerebral arteries in Japanese patients without stroke. Cerebrovasc Dis 1998;8: 267-72.
20. 20. SALONEN JT, SALONEN R. Association of serum low density lipoprotein cholesterol, smoking and hypertension with different manifestations of atherosclerosis. Int J Epidemiol 1990;19:911-17.
21. 21. HEISERMAN JE, DRAYER BP, KELLER PJ, FRAM EK. Intracranial vascular stenosis and occlusion: Evaluation with three dimensional time-of-flight MR angiography. Radiology 1992;185:667-73.
22. 22. CAPLAN LR, GORELIC PB, HIER DB. Race, sex, and occlusive cerebrovascular disease: A review. Stroke 1986;17:648-55.
23. 23. YASAKA M, YAMAGUCHI T, SHICHIRI M. Distribution of atherosclerosis and risk factors in atherothrombotic occlusion. Stroke 1993;24:206-11.
24. 24. MCLEAN JW, TOMLINSON JE, KUANG WJ et al. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 1987;300:132-7.
25. 25. WATTS GF, MAZURKIEWICZ JC, TONGE K, NELSON V, WARBURTON FG, SLAVIN BM. Lipoprotein(a) as a determinant of the severity of angiographically defined carotid atherosclerosis. Q J Med 1995;88:321-6.
26. 26. RIDKER PM, STAMPFER MJ, HENNEKENS CH. Plasma concentration of lipoprotein(a) and the risk of future stroke. JAMA 1995;273:1269-73.
27. 27. MARKUS HS, KAPADIA R, SHERWOOD RA. Relationship between lipoprotein(a) and both stroke and carotid atheroma. Ann Clin Biochem 1997;34:360-5.
28. 28. UTERMANN G, MENZEL HJ, KRAFT HG, DUBA HC, KEMMLER HG, SEITZ C. Lp(a) glycoprotein phenotypes. J Clin Invest 1987;80:458-65.
29. 29. TATSUMI H, MURAI A, MIYAHARA T, FUJIMOTO N, MATSUDA M. Lp(a) lipoprotein as a risk factor for cerebral infarctionapo(a) phenotype distributions in Japanese and their characteristics in patients with cerebral infarction. Jpn J Stroke 1991;13:87-92.
30. 30. VITELLI LL, SHAHAR E, HEISS G et al. Glycosylated hemoglobin level and carotid intimal-medial thickening in nondiabetic individuals. Diabetes Care 1997;20:1454-8.
31. 31. FLORA GC, BAKER AB, LOEWENSON RB, KLASSEN AC. A comparative study of cerebral atherosclerosis in males and females. Circulation 1968;38:859-69.
32. 32. SHINOZAKI K, NARITOMI H, SHIMIZU T et al. Role of insulin resistance associated with compensatory hyperinsulinemia in ischemic stroke. Stroke 1996;27:37-43.